Survival models with competing-risk adjustment (Fine-Gray) and SHAP explainability for per-patient interpretation — designed for clinical trust and regulatory transparency.
Community and GP setting — 10-year CVD risk for fatal and non-fatal MI and stroke. Target AUC ≥ 0.83.
Emergency department — 30-day MACE prediction for chest-pain triage. Target AUC ≥ 0.87.
Lower BMI cut-offs, TG/HDL dyslipidemia, and diabetes weighted 3–4× European amplification.
Gutkha, paan and khaini classified distinctly from cigarette smoking.
Published epidemiological figures, cited for context. They are not AlgoMD results.
SCORE2 was derived from 677,684 Europeans with zero South Asian representation; the HEART Score is Dutch-derived. Both underestimate Indian risk and miss South Asian-specific factors. CPI is designed as the India-specific successor.
Mean age of myocardial infarction in India, versus 58.8 in Europe.
Europeans in the SCORE2 cohort — none of them South Asian.
Diabetes amplifies cardiovascular risk far more than European models assume.
Geography modelled as a distinct risk-context variable.
CPI sources prospective Indian cohorts and registries in sequence, accessed as the company formalises toward a Class B/C submission.
Prospective urban and rural Indian cohorts — formal request post-incorporation.
Hospital MI and state-level ACS registries for the acute module.
National diabetes, NCD and risk-factor surveys.
A Class B/C SaMD submission, planned after four build phases.